IL55869A - 2,4-diamino-5-benzylpyrimidines,their manufacture and pharmaceutical compositions containing them - Google Patents

2,4-diamino-5-benzylpyrimidines,their manufacture and pharmaceutical compositions containing them

Info

Publication number
IL55869A
IL55869A IL55869A IL5586978A IL55869A IL 55869 A IL55869 A IL 55869A IL 55869 A IL55869 A IL 55869A IL 5586978 A IL5586978 A IL 5586978A IL 55869 A IL55869 A IL 55869A
Authority
IL
Israel
Prior art keywords
benzylpyrimidines
diamino
manufacture
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL55869A
Other languages
English (en)
Other versions
IL55869A0 (en
Original Assignee
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sparamedica Ag filed Critical Sparamedica Ag
Publication of IL55869A0 publication Critical patent/IL55869A0/xx
Publication of IL55869A publication Critical patent/IL55869A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02—Monothiocarbamic acids; Derivatives thereof
    • C07C333/08—Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
IL55869A 1977-11-10 1978-11-03 2,4-diamino-5-benzylpyrimidines,their manufacture and pharmaceutical compositions containing them IL55869A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU78487 1977-11-10
CH977678 1978-09-19

Publications (2)

Publication Number Publication Date
IL55869A0 IL55869A0 (en) 1979-01-31
IL55869A true IL55869A (en) 1983-05-15

Family

ID=25705315

Family Applications (1)

Application Number Title Priority Date Filing Date
IL55869A IL55869A (en) 1977-11-10 1978-11-03 2,4-diamino-5-benzylpyrimidines,their manufacture and pharmaceutical compositions containing them

Country Status (22)

Country Link
EP (3) EP0035624B1 (nl)
JP (1) JPS5476586A (nl)
AR (2) AR228423A1 (nl)
AT (1) AT359070B (nl)
AU (1) AU527943B2 (nl)
BR (1) BR7807425A (nl)
CA (1) CA1108611A (nl)
DE (1) DE2847825A1 (nl)
DK (1) DK144418C (nl)
ES (2) ES474921A1 (nl)
FI (1) FI783368A (nl)
FR (4) FR2422647A1 (nl)
GB (3) GB2087378B (nl)
GR (1) GR71725B (nl)
IL (1) IL55869A (nl)
IT (1) IT1100210B (nl)
MC (1) MC1222A1 (nl)
NL (1) NL7811170A (nl)
NO (1) NO783775L (nl)
PH (1) PH15918A (nl)
PT (1) PT68773A (nl)
SE (1) SE7811593L (nl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1138146B (it) * 1981-08-11 1986-09-17 Proter Spa Processo per la produzione della 2,4-diammino-(3,5-dimetossi-4-metos sietossi-benzil)-pirimidina
JPS5888368A (ja) * 1981-11-09 1983-05-26 ザ・ウエルカム・フアウンデ−シヨン・リミテツド ベンジルピリミジン誘導体の製造法
DE3304202A1 (de) * 1983-02-08 1984-08-09 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von aromatischen aldehyden
DE3603577A1 (de) * 1986-02-06 1987-08-13 Joachim K Prof Dr Seydel Neue substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antibakterieller wirksamkeit
EP0639075A1 (en) * 1990-11-14 1995-02-22 Chiron Corporation Specific inhibition of dihydrofolate reductase and compounds therefor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2165362A1 (de) * 1970-12-29 1972-07-27 Nisshin Flour Milling Co. Ltd., Tokio .-Verfahren zur Herstellung von Pyrimidinderivaten
NL7200058A (nl) * 1971-01-21 1972-07-25
IL38276A (en) * 1971-12-01 1976-09-30 Plantex Ltd Process for the preparation of 2,4-diamino-5-substituted benzylpyrimidines
BE798724A (fr) * 1973-04-26 1973-08-16 En Abrege Socechim Soc Et Chim Nouveaux composes chimiques
DK136470B (da) * 1973-11-08 1977-10-17 Hoffmann La Roche Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidinderivater eller salte deraf.
CH605828A5 (nl) * 1974-12-24 1978-10-13 Hoffmann La Roche
DE2635765C3 (de) * 1976-08-09 1979-02-08 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von 2,4-EMamino-5-(3',4'r5'-trimethoxybenzyl)-pyrimidin

Also Published As

Publication number Publication date
PT68773A (en) 1978-12-01
AU527943B2 (en) 1983-03-31
EP0003212A1 (de) 1979-08-08
AU4132378A (en) 1979-05-17
FR2422404B1 (nl) 1983-02-04
AR228423A1 (es) 1983-03-15
DK500178A (da) 1979-05-11
FR2422648A1 (fr) 1979-11-09
ATA803378A (de) 1980-03-15
GB2007669A (en) 1979-05-23
GB2086882B (en) 1982-12-15
PH15918A (en) 1983-04-22
CA1108611A (en) 1981-09-08
EP0003212B1 (de) 1982-03-17
SE7811593L (sv) 1979-05-11
FR2422647A1 (fr) 1979-11-09
AT359070B (de) 1980-10-27
AR222831A1 (es) 1981-06-30
ES474921A1 (es) 1979-12-01
FR2422648B1 (nl) 1983-02-04
IT1100210B (it) 1985-09-28
FR2422647B1 (nl) 1983-02-04
GR71725B (nl) 1983-06-22
MC1222A1 (fr) 1979-07-20
NL7811170A (nl) 1979-05-14
DE2847825A1 (de) 1979-05-17
GB2087378A (en) 1982-05-26
IL55869A0 (en) 1979-01-31
DK144418C (da) 1982-08-09
DK144418B (da) 1982-03-08
EP0035624A3 (en) 1981-09-23
EP0032395B1 (de) 1983-03-23
EP0035624A2 (de) 1981-09-16
EP0035624B1 (de) 1984-07-04
FI783368A (fi) 1979-05-11
FR2422632A1 (fr) 1979-11-09
ES481038A1 (es) 1980-04-01
GB2087378B (en) 1983-01-06
FR2422404A1 (fr) 1979-11-09
JPS5476586A (en) 1979-06-19
BR7807425A (pt) 1979-07-24
EP0032395A1 (de) 1981-07-22
NO783775L (no) 1979-05-11
FR2422632B1 (nl) 1983-02-04
GB2007669B (en) 1982-10-20
GB2086882A (en) 1982-05-19
IT7829638A0 (it) 1978-11-09

Similar Documents

Publication Publication Date Title
IL55423A (en) 3,4,5-trihydroxypiperidine compounds,their production and pharmaceutical compositions containing them
IL56206A0 (en) New 1,2-benzothiazine-1,1-doxide derivatives, their preparation and pharmaceutical compositions containing them
IL61774A0 (en) Cyclooctapeptides,their manufacture and pharmaceutical compositions containing them
IL55382A (en) Propenylamines,their production and pharmaceutical compositions containing them
IL56076A (en) 2 alpha-cyano-4 alpha,5 alpha-epoxyandrostanes,their preparation and pharmaceutical compositions containing them
IL56017A (en) 5-cyano-prostacyclin derivatives,their manufacture and pharmaceutical compositions containing them
NZ187789A (en) 1,3-diazacyclopent-2-eno (2,1-b)(1-thia-o-azacycloalkanes)and pharmaceutical compositions
IL51309A0 (en) New 1,2-benzisothiazolin-3-ones,their preparation and pharmaceutical compositions containing them
IL58415A (en) Substituted octahydro-7-phenylquinolizines,their manufacture and pharmaceutical compositions containing them
IL53926A0 (en) New oxadiazolopyrimidine derivatives, their manufacture and pharmaceutical compositions containing them
IL55207A0 (en) Novel benzodiazepine-diones,their production and pharmaceutical compositions containing them
IL54358A (en) 1-substituted-3-amino-6,7-dialkoxy-1h-1,2,4-benzothiadiazine-1-oxides,their preparation and pharmaceutical compositions containing them
IL55018A (en) Benzylpyrimidines,their manufacture and pharmaceutical compositions containing them
IL54105A0 (en) Novel benzylpyrimidines, their production and pharmaceutical compositions containing them
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
IL56150A0 (en) New tetrapeptides, their manufacture and pharmaceutical compositions containing them
IL54728A (en) Substituted 1,2,4-triazines and pharmaceutical compositions containing them
IL60733A (en) 1-substituted-pyrrolidinones,their manufacture and pharmaceutical compositions containing them
NZ186760A (en) 11hpyrido (2,1-b) quinazolin-11-ones and pharmaceutical compositions
IL55869A (en) 2,4-diamino-5-benzylpyrimidines,their manufacture and pharmaceutical compositions containing them
IL54899A (en) Pyridazinylhydrazones,their preparation and pharmaceutical compositions containing them
IL54001A (en) 2,4-dichlorophenyl-imidazolyl-ethan-ones and-ols,their preparation and pharmaceutical compositions containing them
IL55664A (en) 1,3,4,14b-tetrahydro-2h,10h-pyrazino(1,2-a)pyrrolo-(2,1-c)(1,4)-benzodiazepines,their manufacture and pharmaceutical compositions containing them
IL54342A (en) 2,3 -dihydroergolen-8 -ylmethylurea derivatives, their production and pharmaceutical compositions containing them
IL56021A (en) 2-heterocyclylalklyl-6-methoxy-naphathalenes,their preparation and pharmaceutical compositions containing them